Who is betting on what in AI, and against whom.
Listed AI drug discovery; Boltz-2.
NASDAQ:RXRXA listed AI drug-discovery company. With MIT it released Boltz-2 in June 2025, an open model that predicts binding affinity about a thousand times faster than physics-based free-energy methods.
No capital figures recorded yet.
No people recorded at this lab yet.